Most people focus on trading INJ’s price swings without understanding one key thing: what is the true nature of the token you hold?

By 2025, Injective is no longer just a simple trading tool. Holding INJ is more like owning equity in an “on-chain financial institution”—except this institution has no board of directors, no window-dressed financial statements, and all revenues are transparent and traceable to every single on-chain transaction.

How do traditional banks make money? Through interest rate spreads, service fees, and profit sharing from wealth management products. Injective’s “on-chain bank” logic is actually quite similar, just relocated to the blockchain: global users trade derivatives, transfer assets cross-chain, and participate in RWA contract services on the platform, with every action generating revenue for the ecosystem. These earnings aren't hidden in complex financial reports—they’re distributed directly according to transparent rules.

The distribution mechanism is even more aggressive: each week, 60% of the fees and service revenues are used for token burning auctions (directly boosting token value), 30% goes to stakers (akin to shareholder dividends), and the remaining 10% is invested in ecosystem development. You don’t need to attend shareholder meetings or wait for quarterly reports—on-chain data shows you in real time how this “bank” is performing.

So stop treating INJ as just a speculative asset. What you should be calculating isn’t whether it rises 5% today or falls 3% tomorrow, but rather how much sustainable cash flow this ecosystem can generate, and how much long-term return you can receive as a “shareholder.” Short-term volatility is just market sentiment; long-term value is the real underlying logic.